Citadel Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-571,529
| Closed | -$58.3M | – | 6781 |
|
|
2023
Q2 | $58.3M | Buy |
571,529
+539,322
| +1,675% | +$55M | 0.01% | 371 |
|
|
2023
Q1 | $2.93M | Sell |
32,207
-42,429
| -57% | -$3.86M | ﹤0.01% | 2205 |
|
|
2022
Q4 | $2.84M | Sell |
74,636
-87,179
| -54% | -$3.31M | ﹤0.01% | 2272 |
|
|
2022
Q3 | $4.07M | Sell |
161,815
-66,688
| -29% | -$1.68M | ﹤0.01% | 2046 |
|
|
2022
Q2 | $6.94M | Buy |
228,503
+99,660
| +77% | +$3.03M | ﹤0.01% | 1565 |
|
|
2022
Q1 | $4.22M | Buy |
128,843
+68,422
| +113% | +$2.24M | ﹤0.01% | 2230 |
|
|
2021
Q4 | $1.59M | Buy |
60,421
+54,228
| +876% | +$1.43M | ﹤0.01% | 3296 |
|
|
2021
Q3 | $623K | Buy |
+6,193
| New | +$623K | ﹤0.01% | 4296 |
|
|
2021
Q2 | – | Sell |
-21,229
| Closed | -$2.12M | – | 7318 |
|
|
2021
Q1 | $2.12M | Sell |
21,229
-2,274
| -10% | -$227K | ﹤0.01% | 3100 |
|
|
2020
Q4 | $2.91M | Sell |
23,503
-10,369
| -31% | -$1.28M | ﹤0.01% | 2212 |
|
|
2020
Q3 | $3.3M | Sell |
33,872
-19,908
| -37% | -$1.94M | ﹤0.01% | 1830 |
|
|
2020
Q2 | $8.39M | Sell |
53,780
-22,141
| -29% | -$3.45M | ﹤0.01% | 1192 |
|
|
2020
Q1 | $11M | Buy |
75,921
+41,951
| +123% | +$6.05M | ﹤0.01% | 937 |
|
|
2019
Q4 | $6.95M | Buy |
33,970
+20,598
| +154% | +$4.21M | ﹤0.01% | 1406 |
|
|
2019
Q3 | $1.07M | Buy |
13,372
+5,503
| +70% | +$442K | ﹤0.01% | 2853 |
|
|
2019
Q2 | $742K | Sell |
7,869
-6,828
| -46% | -$644K | ﹤0.01% | 3222 |
|
|
2019
Q1 | $1.26M | Buy |
14,697
+9,267
| +171% | +$792K | ﹤0.01% | 2659 |
|
|
2018
Q4 | $305K | Sell |
5,430
-34,732
| -86% | -$1.95M | ﹤0.01% | 3590 |
|
|
2018
Q3 | $3.28M | Buy |
40,162
+31,880
| +385% | +$2.61M | ﹤0.01% | 1829 |
|
|
2018
Q2 | $290K | Sell |
8,282
-15,970
| -66% | -$559K | ﹤0.01% | 3463 |
|
|
2018
Q1 | $497K | Buy |
+24,252
| New | +$497K | ﹤0.01% | 2915 |
|
|
2017
Q4 | – | Sell |
-8,232
| Closed | -$256K | – | 4383 |
|
|
2017
Q3 | $256K | Buy |
+8,232
| New | +$256K | ﹤0.01% | 3079 |
|